✦ LIBER ✦

[87] EFFICACY OF ANTIVIRAL THERAPY ON DISEASE PROGRESSION IN HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A RANDOMIZED CONTROLLED STUDY

✍ Scribed by J.A. Carrion; M. Navasa; M. Garcia-Retortillo; J.C. Garcia-Pagan; G. Crespo; M. Bruguera; J. Bosch; X. Forns

Book ID: 117375189
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 252 KB
Volume: 46
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(07)61685-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of Antiviral Therapy on Hepatit

Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study

✍ José A. Carrión; Miquel Navasa; Montserrat García–Retortillo; Juan Carlos García 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 482 KB

Antiviral therapy and fibrosis progressi

Antiviral therapy and fibrosis progression in patients with mild–moderate hepatitis C recurrence after liver transplantation. A randomized controlled study

✍ Luca S. Belli; Riccardo Volpes; Ivo Graziadei; Stefano Fagiuoli; Peter Starkel; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 331 KB

A randomized controlled trial of pretran

A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation

✍ Everson, Gregory T.; Terrault, Norah A.; Lok, Anna S.; Rodrigo, Del R.; Brown, R 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 551 KB

Fibrosis Progression and the Pros and Co

Fibrosis Progression and the Pros and Cons of Antiviral Therapy for Hepatitis C Virus Recurrence After Liver Transplantation: A Review

✍ E. De Martin; M. Senzolo; M. Gambato; G. Germani; A. Vitale; F.R. Russo; P. Burr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Factors influencing the progression of f

Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: A retrospective analysis of 939 liver biopsies in a single center

✍ Thomas Walter; Jérôme Dumortier; Olivier Guillaud; Valérie Hervieu; Jean-Yves Sc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

Recurrent hepatitis C after liver transplantation (LT) is a major problem, since up to 30% of patients develop cirrhosis only 5 years after LT in the absence of antiviral therapy. The aim of this study was to examine the rate of progression of fibrosis and its associated risk factors in patients sub

Outcome of recurrent hepatitis C virus a

Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy

✍ Pinelopi Manousou; Dimitrios Samonakis; Evangelos Cholongitas; David Patch; Jame 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

Less potent immunosuppression is considered to reduce the severity of hepatitis C virus (HCV) recurrence after liver transplantation. An optimal regimen is unknown. We evaluated tacrolimus monotherapy versus triple therapy in a randomized trial of 103 first transplants for HCV cirrhosis. One hundred